Evaluation of relationship between the serum levels of inflammatory mediators and ocular injuries induced by sulfur mustard: Sardasht-Iran Cohort Study

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1494-1498

  Ghasemi, Hassan ^a   Ghazanfari, Tooba ^a   Yaraee, Roya ^a   Ghassemi Broumand, Mohammad ^b   Soroush, Mohammad R ^c   Pourfarzam, Shahryar ^a   Masdari, Zahra ^a   Faghihzadeh, Soghrat ^d   Babaei, Mahmoud ^e   Javadi, Mohammad A ^b   Kiuchi, Yoshiaki ^f   Naghizadeh, Mohammad M ^a,g   Owlia, Parviz ^a   Hassan, Zuhair M ^d  

^a SHAHED UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

^e BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f HIROSHIMA UNIVERSITY   (Japan)

^g FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; IL 1 ; IL 1 ; IL 1Ra; IL 6; Iran; MMP 9; Mustard gas; Ocular; TNF

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MUSTARD GAS; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA LIMBUS; ENVIRONMENTAL EXPOSURE; EYE TOXICITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLIT LAMP;

C-REACTIVE PROTEIN; CHEMICAL WARFARE AGENTS; COHORT STUDIES; CONJUNCTIVA; CYTOKINES; DISEASE PROGRESSION; EYE DISEASES; HUMANS; INFLAMMATION MEDIATORS; IRAN; LIMBIC SYSTEM; MATRIX METALLOPROTEINASE 9; MUSTARD GAS; RHEUMATOID FACTOR; TIME FACTORS;

EID: 70350565571     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.021     Document Type: Article

References (40)

1. Cannon JG. Cytokines in aging and muscle homeostasis. J Gerontol A Biol Sci Med Sci 1995 Nov;50 Spec No:120-3.:120-3.
2. Barlow Y., and Willoughby J. Pathophysiology of soft tissue repair. Br Med Bull 48 3 (Jul 1992) 698-711
3. Verma R.P., and Hansch C. Matrix Metalloproteinases (MMPs): chemical-biological functions and (Q) SARs. Bioorg Med Chem 15 (2007) 2223-2268
4. Conaghan P.G., Green M.J., and Emery P. Established rheumatoid arthritis. Bailliere's Best Pract Res Clin Rheumatol 13 4 (1999 Dec) 561-575
5. Ghasemi H., Ghazanfari T., Babaei M., Soroush M., Yaraee R., Ghassemi-Broumand M., et al. Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran. Cutan Ocul Toxicol 27 4 (2008) 317-326
6. Moaiedmohseni S., Ghazanfari T., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Long-term health status 20 years after sulfur mustard exposure. Toxin Rev 28 1 (2009) 3-7
7. Pourfarzam S., Ghazanfari T., Merasizadeh J., Ghanei M., Azimi G., Araghizadeh H., et al. Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran. Toxin Rev 28 1 (2009) 8-13
8. Balali-Mood M., Hefazi M., Mahmoudi M., Jalali E., Attaran D., Maleki M., et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 19 6 (Dec 2005) 713-721
9. Ghasemi H., Ghazanfari T., Yaraee R., Soroush M.R., Ghassemi-Broumand M., Pourfarzam S., et al. Systemic and ocular complications of sulfur mustard: a panoramic review. Toxin Rev 28 1 (2009) 14-23
10. Javadi M.A., Yazdani S., Sajjadi H., Jadidi K., Karimian F., Einollahi B., et al. Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 112 4 (2005) 617-625
11. Javadi M.A., Yazdani S., Kanavi M.R., Mohammadpour M., Baradaran-Rafiee A., Jafarinasab M.R., et al. Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 26 9 (2007) 1074-1078
12. Alekseev V.N., Ketlinskaia O.S., and Gruzinova T.L. Cytokines in the tear fluid and their role in the pathogenesis of ophthalmic herpes. Vestn Ross Akad Med Nauk 57 (1996) 59
13. Moore J.E., McMullen T.C., Campbell I.L., Rohan R., KZaji Y., Afshari N.A., et al. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Invest Ophthalmol Vis Sci 43 2905 (2002) 2915
14. Jacqueminet S., Abdesselam O.B., Chapman M.-J., Nicolay N., Foglietti M.-J., Grimaldi A., et al. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. Clin Chim Acta 367 (2006) 103-107
15. Luo L., Li D.Q., Doshi A., Farley W., Corrales R.M., and Pflugfelder S.C. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 45 12 (2004) 4293-4301
16. Van Leeuwen M.A., and Van Rijswijk M.H. Acute phase proteins in the monitoring of inflammatory disorders. Bailliere's. Clin Rheumatol 8 3 (1994 Aug) 531-552
17. Zaliuniene D., Paunksnis A., Gustiene O., Brazdzionyte J., and Zaliunas R. Pre- and postoperative C-reactive protein levels in patients with cataract and age-related macular degeneration. Eur J Ophthalmol 17 6 (2007) 919-927
18. Ghazanfari T., Faghihzadeh S., Araghizadeh H., Soroush M.R., Yaraee R., Hassan Z.M., et al. Sardasht-Iran Cohort Study of chemical warfare victims: design and methods. Arch Iran Med 12 1 (2009) 5-14
19. Khateri S. Statistical views on late complications of chemical weapons on Iranian CW victims. ASA Newsl (2001)
20. Becker J., Salla S., Dohmen U., Redbrake C., and Reim M. Explorative study of interleukin levels in the human cornea. Graefes Arch Clin Exp Ophthalmol 233 766 (1995) 771
21. Yaraee R., Ghazanfari T., Ebtekar M., Ardestani S.K., Rezaei A., Kariminia A., et al. Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 9 (2009) 1466-1470 (this issue)
22. Fivenson D.P., Faria D.T., Nickoloff B.J., Poverini P.J., Kunkel S., Burdick M., et al. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen 5 4 (1997) 310-322
23. Amano K., Okigaki M., Adachi Y., Fujiyama S., Mori Y., Kosaki A., et al. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. J Mol Cell Cardiol 36 4 (2004) 469-480
24. Biswas P.S., Banerjee K., Zheng M., and Rouse B.T. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J Leukoc Biol 76 4 (2004) 868-875
25. Sijssens K.M., Rijkers G.T., Rothova A., Stilma J.S., Schellekens P.A., and de Boer J.H. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis. Exp Eye Res 85 4 (2007) 443-449
26. Palexas G.N., Sussman G., and Welsh N.H. Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation. Scand J Immunol Suppl 11 (1992) 173-175
27. Palexas G.N., Puren A., Savage N., and Welsh N.H. Serum interleukin (IL-1 beta) in patients with diffuse scleritis. Scand J Immunol Suppl 11 (1992) 171-172
28. Arroyo C.M., Schafer R.J., Kurt E.M., Broomfield C.A., and Carmichael A.J. Response of normal human keratinocytes to sulfur mustard: cytokine release. J Appl Toxicol 20 Suppl 1 (2000) S63-S72
29. Popp T., Egea V., Kehe K., Jochum M., and Ries C. Analysis of matrix metalloproteinase expression in different types of skin and lung cells after exposure to sulfur mustard. Toxicology 233 (2007) 227
30. Ricketts K.M., Santai C.T., France J.A., Graziosi A.M., Doyel T.D., Gazaway M.Y., et al. Inflammatory cytokine response in SM-exposed mouse skin. J Appl Toxicol 20 Suppl 1 (2000) S73-S76
31. Shakarjian M.P., Bhatt P., Gordon M.K., Chang Y.C., Casbohm S.L., Kiser R.C., et al. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J Appl Toxicol 26 3 (2006) 239-246
32. Joussen A.M., Poulaki V., Le M.L., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18 (2004) 1450-1452
33. Klintworth G.K. Hypotheses about the pathogenesis corneal vascularization. In: Klintworth G.K. (Ed). Corneal angiogenesis: a comprehensive critical review (1990), Springer, New York 23-29
34. Ma D.H., Chen J., Kim W.-S., Hao Y.-X., Wu H.-C., Tsai R.J.-F., et al. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophtalmic Res 33 (2001) 353-362
35. Seddon J.M., George S., Rosner B., and Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123 6 (Jun 2005) 774-782
36. Koto T., Nagai N., Mochimaru H., Kurihara T., Izumi-Nagai K., Satofuka S., et al. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 48 9 (2007) 4328-4334
37. Klein R., Klein B.E., Knudtson M.D., Wong T.Y., and Tsai M.Y. Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol 124 1 (Jan 2006) 87-94
38. Loukovaara S., Immonen I., Koistinen R., Hiilesmaa V., and Kaaja R. Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes. Eye 19 4 (2005 Apr) 422-430
39. Zorena K., Mysliwska J., Mysliwiec M., Balcerska A., Hak L., Lipowski P., et al. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediat Inflamm 2007 (2007) 92196
40. Begic Z., Terzic R., Dinarevic S., Buljina A., and Meholjic A. Prognostic significance of juvenile chronic arthritis onset types. Med Arh 58 3 (2004) 163-166